Generic Medicine Info
Oral soln: May be taken with or without food. Take w/ a glass of water or soft drink to mask bitter taste.
Cerebral haemorrhage, Huntington's chorea. ESRD or severe renal impairment (CrCl <20 mL/min).
Special Precautions
Patient with severe haemorrhage, increased risk of bleeding (e.g. gastrointestinal ulcer), underlying haemostatic disorder, history of haemorrhagic cerebrovascular accident (CVA). Patient undergoing major surgery including dental surgery or receiving anticoagulants or antiplatelet drugs (including low dose aspirin). Avoid abrupt withdrawal. Renal impairment. Children and elderly. Pregnancy and lactation. Patient CounsellingThis drug may cause drowsiness, weakness and impaired coordination, if affected, do not drive or operate machinery. Monitoring Parameters Monitor renal function.
Adverse Reactions
Significant: Bleeding disorder, CNS effects (e.g. impaired coordination, weakness, drowsiness). General disorders and administration site conditions: Rarely, pyrexia, inj site pain (IV). Investigations: Weight gain. Nervous system disorders: Hyperkinesia. Psychiatric disorders: Nervousness, depression. Vascular disorders: Rarely, thrombophlebitis, hypotension (IV).
Drug Interactions
Concomitant use with thyroid hormones may cause confusion, irritability and sleep disorder. May increase the effects of anticoagulants (e.g. acenocoumarol) or antiplatelet agents (e.g. aspirin).
CIMS Class
Nootropics & Neurotonics/Neurotrophics
ATC Classification
N06BX03 - piracetam ; Belongs to the class of other psychostimulants and nootropics.
Disclaimer: This information is independently developed by CIMS based on piracetam from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in